Prevention of vaginal dryness in perimenopausal women. Supplementation with Lady Prelox®.


Journal

Minerva ginecologica
ISSN: 1827-1650
Titre abrégé: Minerva Ginecol
Pays: Italy
ID NLM: 0400731

Informations de publication

Date de publication:
Dec 2019
Historique:
entrez: 18 2 2020
pubmed: 18 2 2020
medline: 17 6 2020
Statut: ppublish

Résumé

The aim of this pilot registry study was to use a standardized supplement (Lady Prelox®, Horphag Research) - including Pycnogenol®, l-arginine, L-citrulline and rose hip extract - to improve signs and symptoms associated with vaginal dryness in pre and post-menopausal healthy women. A group of women used only a standard management (SM) and a second group added Lady Prelox®. Four groups of women were included in the study. 34 pre-menopausal and 38 post-menopausal women took Lady Prelox®, four tablets daily for 8 weeks and 33 pre-menopausal women and 35 post-menopausal women served as controls. No safety problems were observed with the supplement that was well tolerated. The subgroups of controls and supplemented subjects were comparable in both the pre- and post-menopausal groups. Among pre-menopausal women, results of the female sexual function index (FSFI) were significantly improved with the supplement in comparison with the control subjects' group (P<0.05). The results of the FSFI questionnaire for post-menopausal women indicated a significant improvement at 8 weeks with Lady Prelox® (P<0.05) in comparison with controls. Preclinical items (vaginal dryness, pain/discomfort during intercourse, mucus, minimal infections, presence of candida and oxidative stress) were significantly improved (P<0.05) with Lady Prelox®) in comparison to minimal changes with the SM group. These measurements included all women. The effects of the supplementation with Lady Prelox® on vaginal dryness were significant. The supplement was well accepted and revealed no side effects or tolerability problems. Further studies are evaluating the effects of Lady Prelox® on other aspects of the menopausal transition that may alter the quality of life of most women in advanced age. A gentle approach with suitable dietary supplementation, represents a promising option for addressing common challenges that women experience in such conditions.

Sections du résumé

BACKGROUND BACKGROUND
The aim of this pilot registry study was to use a standardized supplement (Lady Prelox®, Horphag Research) - including Pycnogenol®, l-arginine, L-citrulline and rose hip extract - to improve signs and symptoms associated with vaginal dryness in pre and post-menopausal healthy women. A group of women used only a standard management (SM) and a second group added Lady Prelox®.
METHODS METHODS
Four groups of women were included in the study. 34 pre-menopausal and 38 post-menopausal women took Lady Prelox®, four tablets daily for 8 weeks and 33 pre-menopausal women and 35 post-menopausal women served as controls.
RESULTS RESULTS
No safety problems were observed with the supplement that was well tolerated. The subgroups of controls and supplemented subjects were comparable in both the pre- and post-menopausal groups. Among pre-menopausal women, results of the female sexual function index (FSFI) were significantly improved with the supplement in comparison with the control subjects' group (P<0.05). The results of the FSFI questionnaire for post-menopausal women indicated a significant improvement at 8 weeks with Lady Prelox® (P<0.05) in comparison with controls. Preclinical items (vaginal dryness, pain/discomfort during intercourse, mucus, minimal infections, presence of candida and oxidative stress) were significantly improved (P<0.05) with Lady Prelox®) in comparison to minimal changes with the SM group. These measurements included all women.
CONCLUSIONS CONCLUSIONS
The effects of the supplementation with Lady Prelox® on vaginal dryness were significant. The supplement was well accepted and revealed no side effects or tolerability problems. Further studies are evaluating the effects of Lady Prelox® on other aspects of the menopausal transition that may alter the quality of life of most women in advanced age. A gentle approach with suitable dietary supplementation, represents a promising option for addressing common challenges that women experience in such conditions.

Identifiants

pubmed: 32064827
pii: S0026-4784.19.04466-6
doi: 10.23736/S0026-4784.19.04466-6
doi:

Substances chimiques

Flavonoids 0
Lady Prelox 0
Citrulline 29VT07BGDA
Arginine 94ZLA3W45F

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

434-441

Auteurs

Maria R Cesarone (MR)

IRVINE3 Labs &amp; Pap/Pea Screening Project and the International Irvine Network, Pescara, Italy.
IAAPS, International Agency for Pharma Standard Supplements, Chieti, Italy.

Gianni Belcaro (G)

IRVINE3 Labs &amp; Pap/Pea Screening Project and the International Irvine Network, Pescara, Italy - cardres@abol.it.
IAAPS, International Agency for Pharma Standard Supplements, Chieti, Italy.

Claudia Scipione (C)

IRVINE3 Labs &amp; Pap/Pea Screening Project and the International Irvine Network, Pescara, Italy.
IAAPS, International Agency for Pharma Standard Supplements, Chieti, Italy.

Valeria Scipione (V)

IRVINE3 Labs &amp; Pap/Pea Screening Project and the International Irvine Network, Pescara, Italy.
IAAPS, International Agency for Pharma Standard Supplements, Chieti, Italy.

Mark Dugall (M)

IRVINE3 Labs &amp; Pap/Pea Screening Project and the International Irvine Network, Pescara, Italy.
IAAPS, International Agency for Pharma Standard Supplements, Chieti, Italy.

Shu Hu (S)

Department of Medical, Oral Sciences and Biotechnologies, G. D'Annunzio University, Pescara, Italy.

Roberto Cotellese (R)

Department of Medical, Oral Sciences and Biotechnologies, G. D'Annunzio University, Pescara, Italy.

Beatrice Feragalli (B)

IRVINE3 Labs &amp; Pap/Pea Screening Project and the International Irvine Network, Pescara, Italy.
IAAPS, International Agency for Pharma Standard Supplements, Chieti, Italy.

Andrea Ledda (A)

IRVINE3 Labs &amp; Pap/Pea Screening Project and the International Irvine Network, Pescara, Italy.
IAAPS, International Agency for Pharma Standard Supplements, Chieti, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH